Invex reports success in using exenatide to delay Alzheimers in ‘microtissue’ simulation
Invex Therapeutics (ASX:IXC) has had success simulating the use of Exenatide to…
Invex Therapeutics Ltd (ASX:IXC)
About Invex Therapeutics Ltd
Key Information
IXC In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 16/12/2024 | Price Sensitive PS Improved Neuronal Cell Survival in 3D Model of Alzheimer's | 277.69KB | 329 |
| 26/11/2024 | Results of Meeting | 195.17KB | 216 |
| 26/11/2024 | Chair's Address to Shareholders | 208.73KB | 230 |
| 17/10/2024 | Addendum to Notice of Annual General Meeting | 123.34KB | 280 |
| 14/10/2024 | Letter to Shareholders AGM | 121.57KB | 332 |
| 14/10/2024 | Notice of Annual General Meeting | 243.61KB | 178 |
| 08/10/2024 | Price Sensitive PS Quarterly Activities Report and Appendix 4C | 393.01KB | 374 |
| 23/09/2024 | Date of AGM and Closing Date for Director Nominations | 170.5KB | 242 |